SCHEMBL23213703

SCHEMBL23213703

CCOC(=O)c1ncn2c1CCCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRG2 P18507 17/20 0.47
▸ GABRB3 P28472 17/20 0.47
▸ GABRA5 P31644 17/20 0.47
▸ GABRA1 P14867 4/20 0.46
▸ GABRA3 P34903 4/20 0.46
▸ GABRA2 P47869 4/20 0.46
▸ GABRA6 Q16445 3/20 0.46
▸ GABRB2 P47870 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15247956 0.83 GABRG2 (0.48) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL22824624 0.81 HPGD (0.40) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL20691676 0.79 GABRG2 (0.42) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL26045560 0.79 HPGD (0.39) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL23144566 0.79 GABRG2 (0.43) GABRG2GABRB3GABRA5GABRA1GABRA3
Hydrochloric Acid SCHEMBL17798425 0.78 GABRG2 (0.42) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL23547524 0.77 HPGD (0.38) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL22821219 0.77 MEN1 (0.40) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL23090032 0.77 MEN1 (0.40) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL23090034 0.77 MEN1 (0.40) GABRG2GABRB3GABRA5GABRA1GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114630822-B Biaryl dihydroorotate acid dehydrogenase inhibitors 詹森生物科技公司 2024-10-01 — — CN disclosed
US-20240158414-A1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 2024-05-16 — — US disclosed
EP-4041714-B1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH INC (US) 2023-12-13 — — EP disclosed
EP-4041714-A1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS Janssen Biotech, Inc. (US) 2022-08-17 — — EP disclosed
CN-114630822-A Biaryl dihydroorotate dehydrogenase inhibitors 詹森生物科技公司 2022-06-14 — — CN disclosed
WO-2021070132-A1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158414-A1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD GABRG2 2803/4885GABRB3 1818/4885GABRA5 3448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback